118 related articles for article (PubMed ID: 21538633)
1. Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study.
Nunes PM; Jones JG; Rolo AP; Palmeira CM; Carvalho RA
NMR Biomed; 2011 Nov; 24(9):1145-58. PubMed ID: 21538633
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
[TBL] [Abstract][Full Text] [Related]
3. [UDCA in the treatment of nonalcoholic fatty liver disease].
Grigor'eva IN
Eksp Klin Gastroenterol; 2011; (9):125-31. PubMed ID: 22629789
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis.
Lukivskaya O; Zavodnik L; Knas M; Buko V
Adv Med Sci; 2006; 51():54-9. PubMed ID: 17357278
[TBL] [Abstract][Full Text] [Related]
5. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet.
Nakano H; Nagasaki H; Barama A; Boudjema K; Jaeck D; Kumada K; Tatsuno M; Baek Y; Kitamura N; Suzuki T; Yamaguchi M
Hepatology; 1997 Sep; 26(3):670-8. PubMed ID: 9303498
[TBL] [Abstract][Full Text] [Related]
6. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
Raju J; Bird RP
Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status.
Vendemiale G; Grattagliano I; Caraceni P; Caraccio G; Domenicali M; Dall'Agata M; Trevisani F; Guerrieri F; Bernardi M; Altomare E
Hepatology; 2001 Apr; 33(4):808-15. PubMed ID: 11283843
[TBL] [Abstract][Full Text] [Related]
8. Tibolone impairs glucose and fatty acid metabolism and induces oxidative stress in livers from female rats.
de Oliveira MC; Martins-Maciel ER; Comar JF; Yamamoto NS; Bracht A; Ishii-Iwamoto EL; Salgueiro-Pagadigorria CL
Eur J Pharmacol; 2011 Oct; 668(1-2):248-56. PubMed ID: 21762690
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.
Ali MH; Messiha BA; Abdel-Latif HA
Pharm Biol; 2016 Jul; 54(7):1198-208. PubMed ID: 26134756
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
Perez MJ; Macias RI; Duran C; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
J Hepatol; 2005 Aug; 43(2):324-32. PubMed ID: 15970352
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profiling of livers and blood from obese Zucker rats.
Serkova NJ; Jackman M; Brown JL; Liu T; Hirose R; Roberts JP; Maher JJ; Niemann CU
J Hepatol; 2006 May; 44(5):956-62. PubMed ID: 16223541
[TBL] [Abstract][Full Text] [Related]
12. Hepatic and very low-density lipoprotein fatty acids in obese offspring of overfed dams.
Bouanane S; Merzouk H; Benkalfat NB; Soulimane N; Merzouk SA; Gresti J; Tessier C; Narce M
Metabolism; 2010 Dec; 59(12):1701-9. PubMed ID: 20494379
[TBL] [Abstract][Full Text] [Related]
13. Subnormothermic machine perfusion protects steatotic livers against preservation injury: a potential for donor pool increase?
Vairetti M; Ferrigno A; Carlucci F; Tabucchi A; Rizzo V; Boncompagni E; Neri D; Gringeri E; Freitas I; Cillo U
Liver Transpl; 2009 Jan; 15(1):20-9. PubMed ID: 19109848
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
[TBL] [Abstract][Full Text] [Related]
15. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model.
van Werven JR; Marsman HA; Nederveen AJ; ten Kate FJ; van Gulik TM; Stoker J
Magn Reson Imaging; 2012 Jan; 30(1):112-21. PubMed ID: 21940131
[TBL] [Abstract][Full Text] [Related]
16. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.
Nowak G; Norén UG; Wernerson A; Marschall HU; Möller L; Ericzon BG
Transpl Int; 2005 May; 17(12):804-9. PubMed ID: 15815896
[TBL] [Abstract][Full Text] [Related]
17. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
18. Effect of ursodeoxycholic acid on hepatic steatosis in rats.
Okan A; Astarcioglu H; Tankurt E; Sagol O; Altekin E; Astarcioglu I; Gonen O
Dig Dis Sci; 2002 Nov; 47(11):2389-97. PubMed ID: 12452368
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of pentoxifylline on microvesicular steatotic livers submitted to a prolonged cold ischemia.
Arnault I; Bao YM; Sebagh M; Anjo A; Dimicoli JL; Lemoine A; Delvart V; Adam R
Transplantation; 2003 Jul; 76(1):77-83. PubMed ID: 12865790
[TBL] [Abstract][Full Text] [Related]
20. Hepatic lipid and carbohydrate metabolism in rats fed a commercial mixture of conjugated linoleic acids (Clarinol G-80).
Giudetti AM; Beynen AC; Lemmens AG; Gnoni GV; Geelen MJ
Eur J Nutr; 2005 Feb; 44(1):33-9. PubMed ID: 15309462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
